Effect of ammonium metavanadate on the murine immune response.
Female B6C3F1 mice were exposed to ammonium metavanadate (NH4VO3) by intraperitoneal injection every 3 d at 2.5, 5.0, or 10 mg V/kg for 3, 6, or 9 w and were then assayed for alterations in immunoresponsiveness. Resistance to Escherichia coli endotoxin lethality increased in a dose-dependent manner up to 6 w of exposure, while resistance to viable gram-positive Listeria lethality was depressed in a dose-dependent manner. Comparison of LD20 values indicated a 250-fold decrease in resistance to Listeria at the lowest vanadium exposure and a 40% increase in resistance to endotoxin after the highest vanadium exposure. Peritoneal macrophage phagocytic capacities were decreased in a dose-dependent manner, but viabilities remained unaffected. Rosetting capacity of splenic lymphocytes was increased following vanadium exposure. Liver and splenic enlargement was observed, and examination of splenic tissue indicated enhanced formation of megakaryocytes and red blood cell precursors. Subchronic exposure to vanadium may thus disrupt the normal function of the immune system.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004731:Endotoxins / Q000633:toxicity; D004926:Escherichia coli; D005260:Female; D007113:Immunity, Innate / Q000187:drug effects; D008089:Listeria monocytogenes / Q000276:immunology / Q000472:pathogenicity; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects; D012397:Rosette Formation; D013154:Spleen / Q000187:drug effects; D014639:Vanadium / Q000494:pharmacology*
D004731:Endotoxins; D014639:Vanadium